Wyeth Holdings Corporation v. Sandoz Inc.
1:09-cv-00955
📡 5G SEP • ETSI DeclaredOverview
Parties
Defendant
Wyeth LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Plaintiff
Wyeth-Ayerst Lederle LLC Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Cross Defendant
Wyeth Holdings Corporation Operating Company
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell
Morris, Nichols, Arsht & Tunnell, 1201 North Market Street
Counter Claimant
Sandoz Inc. Operating Company
Represented By
9 Attorneys ListedShaw Keller LLP
300 Delaware Avenue, Suite 1120, Wilmington, DE 19801
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Shaw Keller LLP
300 Delaware Avenue, Suite 1120, Wilmington, DE 19801
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° RadarMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
Initiative for Responsibility in Drug Pricing LLC v. Wyeth LLC et al.
Pfizer Inc v. Mylan Laboratories Limited
Standard Essential Patent (SEP) & FRAND Intelligence
5G SEP • ETSI Declared High-Probability SEP ActionEssential standard specifications, SSO declaration status, and FRAND antitrust defense evaluation
Injunction Restrictions & FRAND Defense Leverage (CJEU Huawei v. ZTE Framework)
Permanent Injunction RestrictedAsserted by recognized SEP declarant. Under the CJEU Huawei v. ZTE test, injunctions are barred if the defendant qualifies as a willing licensee.
Patents Involved
There are 2 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
USRE40183
7-Substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
|
Filed: 2005-06-03
Issued: 2008-03-25
|
Expired (Term Ended)
Expires: 2016-04-09
|
|
|
US7879828
Tigecycline compositions and methods of preparation
|
Filed: 2006-03-13
Issued: 2011-02-01
|
Active (2.2 yrs remaining)
+1060d PTA
Expires: 2029-02-05
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).
Procedural Motions & Interlocutory Orders
Total Motions
28
Dispositive
10
Granted
0
Denied
0
Pending / Review
28
Motions by Category
Key Dispositive Motions & Rulings